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Abstract
Competence stimulating peptide (CSP) is a 17-amino acid peptide pheromone secreted by Streptococcus pneumoniae. Upon
binding of CSP to its membrane-associated receptor kinase ComD, a cascade of signaling events is initiated, leading to
activation of the competence regulon by the response regulator ComE. Genes encoding proteins that are involved in DNA
uptake and transformation, as well as virulence, are upregulated. Previous studies have shown that disruption of key
components in the competence reguloninhibits DNA transformation and attenuates virulence. Thus, synthetic analogues that
competitively inhibit CSPs may serve as attractive drugs to control pneumococcal infection and to reduce horizontal gene
transfer during infection. We performed amino acid substitutions on conserved amino acid residues of CSP1 in an effort to
disable DNA transformation and to attenuate the virulence of S. pneumoniae. One of the mutated peptides, CSP1-E1A,
inhibited development of competence in DNA transformation by outcompeting CSP1 in time and concentration-dependent
manners. CSP1-E1A reducedtheexpressionof pneumococcal virulence factors cholinebinding protein D (CbpD)andautolysin
A (LytA) in vitro, and significantly reduced mouse mortality after lung infection. Furthermore, CSP1-E1A attenuated the
acquisition of an antibiotic resistance gene and a capsule gene in vivo. Finally, we demonstrated that the strategy of using a
peptide inhibitor is applicable to other CSP subtype, including CSP2. CSP1-E1A and CSP2-E1A were able to cross inhibit the
induction of competence and DNA transformation in pneumococcal strains with incompatible ComD subtypes. These results
demonstrate the applicability of generating competitive analogues of CSPs as drugs to control horizontal transfer of antibiotic
resistance and virulence genes, and to attenuate virulence during infection by S. pneumoniae.
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Introduction
Streptococcus pneumoniae is one of the most important pathogens
that cause bacterial pneumonia, otitis media, meningitis and sepsis
[1–3]. The incidence of antibiotic resistance in S. pneumoniae has
increased dramatically in the recent decades [4–6]. The
acquisition and spread of antibiotic resistance genes in S.
pneumoniae is at least partly due to genetic transformation, which
occurs when the bacteria enter the competent state [7–9]. The
binding of competence stimulating peptide (CSP) to its membrane-
associated histidine kinase receptor ComD initiates competence in
S. pneumoniae [7–10]. Upon interacting with CSP, ComD
phosphorylates the cognate transcriptional regulator ComE [11–
13]. ComE then initiates the transcription of a set of 24 genes
(early genes), including comX. As an alternative sigma factor,
ComX positively regulates the transcription of 81 genes (late
genes) in the competence regulon [14–15]. Some of these late
genes encode effectors for DNA uptake and recombination [14].
DNA sequence analysis from 60 pneumococcal isolates predicts
the existence of six distinct CSP subtypes [16,17]. However, an
overwhelming majority of S. pneumoniae strains produce two of
these subtypes: CSP1 or CSP2 [17]. Furthermore, apart from
CSP1 and CSP2, the ability of other CSP subtypes to induce DNA
transformation has not been analyzed. There are two major
corresponding variants of ComD, named ComD1 and ComD2
[18]. CSP1 and CSP2 share 50% amino acid identity. The major
sequence variation between CSP1 and CSP2 occurs in the central
region of these peptides, which confers receptor specificity [19]. In
contrast, the first three amino acid residues of the N-terminus and
the last two amino acid residues of the C-terminus are conserved
between CSP1 and CSP2. Competence in pneumococcal strains
with the ComD1 receptor could be induced more efficiently with
the ‘‘compatible’’ CSP1. In contrast, ComD2 strains are more
sensitive to induction by the ‘‘compatible’’ CSP2 [19].
Competence for DNA transformation plays a crucial role in the
ability of S. pneumoniae to gain virulence and antibiotic resistance
genes from other species. Importantly, in recent years, the
competence regulon of S. pneumoniae has been shown to cross
regulate virulence [20–24]. For example, Lau et al [20] reported
that a loss of function in ComB, an accessory protein to the ComA
ABC transporter required for the export of CSP, as well as a loss of
function in the ComD histidine kinase, attenuate the ability of S.
pneumoniae to cause pneumonia and bacteremia in mice. This
report has been subsequently confirmed by other studies [21–23].
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may mediate the release of pneumolysin, as well as the cell wall
component lipoteichoic acid (LTA), the former being an important
virulence factor of S. pneumoniae [23,24]. Microarray analysis has
indicated that CSP induces the transcription of both virulence and
stress responsive genes [14]. These above-mentioned studies
indicate that activation of the competence regulon is not only
essential for DNA uptake and transformation, but also important
for virulence. Therefore, the competence regulon represents an
attractive drug target to combat both pneumococcal infections and
the spread of antibiotic resistance genes.
In thisstudy, we performed amino acid substitutions inCSP1 and
CSP2, and examined the ability of these CSP variants to inhibit the
development ofcompetence, horizontal gene transfer, andvirulence
of S. pneumoniae both in vitro and in mice. One of these modified
peptides, CSP1-E1A, was able to competitively inhibit the
development of competence for DNA transformation and expres-
sion of virulence gene in vitro. Importantly, CSP1-E1A was able to
attenuatethevirulenceofS.pneumoniaeduringlunginfectioninmice,
as well as inhibiting the ability of pneumococcus to acquire both an
antibiotic resistance gene and a capsule gene during mouse models
of acute pneumonia and bacteremia infections. Significantly, we
demonstrated that the same amino acid substitution on CSP2
(CSP2-E1A) also inhibits CSP2-mediated competence develop-
ment. Moreover, both CSP1-E1A and CSP2-E1A were capable of
cross inhibiting the induction of competence regulon mediated by
incompatible receptors, ComD2 and ComD1, respectively.
Results
The first and the third amino acid residues on the N
terminus of CSP1 are critical for the induction of
competence
Because amino acid residues in the central region of CSP1 are
important for receptor specificity [19], we hypothesized that
conserved amino acid residues on both the N-terminus and the
C-terminus of CSP1 are important for its ability to induce
competence. By amino acid substitutions or deletions of the first
three amino acid residues on the N-terminus and of the last two
amino acids on the C-terminus, we synthesized five CSP1 variants
(Figure 1). The ability of these modified peptides to induce
competence in S. pneumoniae wild-type strain D39 (Table 1) grown
in Todd Hewitt Broth (THB) was compared to that of CSP1 by: (i)
monitoring the transformation frequency of a rpsL gene that
confers resistance to streptomycin [25], and (ii) monitoring the
promoter activity of the competence specific sigma factor gene
comX. Induction of ComX indicates that S. pneumoniae cells have
entered a competent state. The promoter activity of comX was
monitored by assaying the ß-galactosidase activity in
D39pcomX::lacZ, a D39 derivative with a lacZ gene fused behind
the comX promoter (Table 1) [26]. Deletion or substitution of either
of the two lysine (K) residues on the C-terminus (CSP1-
K16DK17D, CSP1-DK16DK17) did not alter the ability of these
peptides to induce competence (Fig. 2A–2B). In contrast,
substitution of the first amino acid (glutamate to alanine) (CSP1-
E1A) severely reduced the ability of this peptide to induce comX
(Fig. 2A) and DNA transformation (Fig. 2B). CSP1-E1A could
only induce about 1% of comX promoter activity and . 3 logs
lower DNA transformation when compared to CSP1. Similarly,
alanine substitution of the third residue of the N terminus (CSP1-
R3A) impaired its ability to induce both comX and DNA
transformation (Fig. 2A–2B). In contrast, alanine substitution of
the second amino acid residue on the N terminus (CSP1-M2A) did
not alter its ability to induce both comX and DNA transformation
(Fig. 2A–2B).
CSP1-E1A but not CSP1-R3A out-competes and inhibits
CSP1-mediated comX induction in a dose and time
dependent manner
As presented in Figure 2, two modified CSP peptides—CSP-
E1A and CSP-R3A—are attenuated in their ability to induce the
comX gene and the competence of DNA transformation. We
examined the ability of these two peptides to competitively inhibit
the induction of competence by CSP1. D39pcomX::lacZ cells
were exposed to 100 ng of CSP1 alone or simultaneously to
increasing amounts of CSP1-E1A (Fig. 3A) or CSP1-R3A (Fig. 3B).
In the absence of CSP1-E1A, CSP1 induced the promoter activity
of comX gene to approximately 45 Miller units of b-galactosidase.
However, in the presence of CSP1-E1A, the ability of CSP1 to
induce comX (Fig. 3A) was severely inhibited in a concentration
dependent manner. CSP1-E1A by itself only induced low
expression of comX. In contrast, even though CSP1-R3A by itself
was unable to induce the expression of comX, it did not
competitively inhibit CSP1-dependent comX expression (Fig. 3B).
These results suggest that CSP1-E1A has the unique ability to
competitively inhibit the ability of CSP1 to induce competence.
CSP-E1A but not CSP1-R3A inhibits CSP1-mediated
genetic transformation
Because of their inability to induce competence and DNA
transformation, we next examined whether CSP1-E1A and CSP1-
R3A were able to competitively inhibit CSP1-mediated DNA
transformation. In vitro transformation with the rpsL gene was
performed with S. pneumoniae D39 cells exposed to 100 ng of CSP1
alone or simultaneously in the presence of increasing amounts of
CSP1-E1A or CSP1-R3A. As expected, in the absence of CSP1-
E1A, CSP1 induced DNA uptake and transformation at high
frequency (Fig. 3C). However, the presence of increasing concen-
trations of CSP1-E1A drastically inhibited the transformation of
Author Summary
Streptococcus pneumoniae is a major cause of pneumonia,
ear infection and meningitis. Antibiotic resistance among
S. pneumoniae isolates is increasingly a major clinical
problem. The acquisition of antibiotic resistance genes in
S. pneumoniae is controlled by a peptide pheromone
called competence-stimulating peptide (CSP). CSP binds to
a receptor called ComD, which in turn activates its cognate
transcription factor ComE to initiate DNA uptake and
integration into the S. pneumoniae genome. CSP-ComD/E
also regulates the expression of virulence factors required
for infection. In this study, multiple synthetic analogues of
CSP pheromone were examined for their ability to inhibit
acquisition of exogenous DNA, and to control infection by
S. pneumoniae in mice. Two of these analogues, CSP1-E1A
and CSP2-E1A, competitively inhibit the ability of S.
pneumoniae to acquire the streptomycin resistance rpsL
gene and the capsule gene cap3A during mouse models of
acute pneumonia and bacteremia. CSP1-E1A also reduces
mouse mortality during lung infection by S. pneumoniae.
This is the first demonstration of the use of CSP analogues
to attenuate virulence and to inhibit acquisition of an
antibiotic resistance gene in S. pneumoniae. Because the
CSP-ComD/E system is conserved among many pathogen-
ic bacteria, CSP analogues may be applicable to reduce the
spread of antibiotic resistance genes and to treat
infections.
CSP Analogues Inhibits Pneumococcal Competence
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E1A reduced CSP1-mediated transformation by 5.6-fold. Interest-
ingly, increasing concentration of CSP1-R3A failed to competitively
inhibit the ability of CSP1 to induce DNA transformation in D39
cells (Fig. 3D). These results are consistent with the inability of
CSP1-R3A to inhibit the induction of comX by CSP1 (Fig. 3B).
Collectively, these data suggest that CSP1-E1A is uniquely capable
of competitively inhibiting CSP1-mediated competence induction
and DNA transformation.
CSP1-E1A inhibits the competence regulon in a time-
dependent manner
Because CSP1-E1A is capable of competitively inhibiting CSP1-
mediated competence induction in S. pneumoniae, we examined
whether this inhibition occurred in a time-dependent manner.
D39pcomX::lacZ cells were pre-exposed to 100 ng/ml CSP1,
then chased by the addition of CSP1-E1A at indicated time
intervals. Activation of the comX promoter was calculated against
D39pcomX::lacZ cells exposed to CSP1 alone (100%). As shown
in Figure 4, CSP1-E1A at concentration of 100 ng/ml was able to
inhibit approximately 40–50% of comX induction 10 minutes after
pre-induction with CSP1. The inhibition was abolished at
approximately 30 minutes after preinduction with CSP1. At the
concentration of 800 ng/ml, CSP1-E1A was highly effective, and
able to inhibit 50% of CSP1-mediated comX induction 25 min
after pre-induction by CSP1. These results suggest that under our
in vitro experimental conditions, 30 min was roughly the time span
required for the distribution and binding of CSP1 to ComD to
prevent competitive inhibition by CSP1-E1A. In addition, these
results also indicate that 30 minutes was approximately the
amount of time required for establishment of full competence
when S. pneumoniae D39 cells are exposed to CSP1.
CSP1-E1A delays and inhibits the development of
spontaneous competence in vitro in a concentration
dependent manner
During its normal growth, S. pneumoniae cells spontaneously
enter a developmental stage of competence for DNA uptake and
Figure 1. Amino acid sequences of CSP1 and CSP2, and their analogues. Modified CSPs were synthesized based on the sequence of CSP1 or
CSP2 by amino acid substitutions or by deletion. The ability of each CSP analogue to induce competence and to competitively inhibit CSP1 or CSP2-
mediated competence is presented. *No represents , 1% of CSP1 or CSP2 activity during the induction of competence.
doi:10.1371/journal.ppat.1002241.g001
Table 1. S. pneumoniae strains used in this study.
Strains Relevant characteristics Reference
D39 Wild-type (CSP1, ComD1) [49]
D39pcomX::lacZ D39 with a promoterless lacZ reporter gene behind comX promoter This work
D39pcbpD::lacZ cells D39 with a promoterless lacZ reporter gene behind cbpD promoter This work
TIGR4 Wild-type (CSP2, ComD2) [51]
TIGR4pcomX::lacZ TIGR4 with a promoterless lacZ reporter gene behind comX promoter This work
R6 A derivative of D39 without capsule [50]
CPM3 R6 with a promoterless lacZ reporter gene behind comX promoter [26]
CP1298 R6 strain with a modified rpsL gene that confers resistance to streptomycin [27]
0100993 Wild-type, serotype 3 [20]
cap3A A non-encapsulated 0100993 derivative generated by deleting cap3A gene using Janus cassette This work
doi:10.1371/journal.ppat.1002241.t001
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CSP1-E1A competitively inhibits the competence development in
pneumococcal cells exposed to exogenously supplied CSP1, we
further investigated its ability to suppress spontaneous develop-
ment of competence. D39pcomX::lacZ cells grown in THB (pH
8.3) were exposed to sterile water (control) or to CSP1-E1A. The
promoter activity of comX began to increase dramatically in the
D39pcomX::lacZ cells incubated with sterile water at approxi-
mately 90 min (Fig. 5A). In contrast, in the D39pcomX::lacZ cells
treated with 100 ng or 1 mg of CSP1-E1A, the induction of comX
promoter was delayed for 30 min and 60 min, respectively
(Fig. 5A). Furthermore, the maximum level comX promoter activity
was only 38% in cells treated with 1 mg of CSP1-E1A when
compared to those cells treated with sterile water. CSP1-E1A at
the concentration of 10 mg/ml completely abolished the induction
of comX promoter in D39 (Fig. 5A). Similarly, CSP1-E1A delayed
and inhibited the promoter activity of a virulence gene cbpD, a late
gene in the competence regulatory circuit, in a concentration
dependent manner (Fig. 5B). CSP1-E1A did not interfere with the
growth D39 cells (Fig. 5C). These results suggest that CSP1-E1A
has the ability to delay and inhibit spontaneous competence
development during normal growth in S. pneumoniae in a
concentration-dependent manner.
CSP1-E1A attenuates the expression of S. pneumoniae
virulence factor in vitro
We and others have previously shown that the competence
regulon regulates both DNA transformation and virulence [20–
24], although the mechanism behind this regulation is not fully
understood. Guiral et al [23] have proposed a possible connection
between competence induced cell lysis and virulence. Induction of
competence triggers the expression of the murein hydrolases
autolysin A (LytA) and Choline-Binding Protein D (CbpD).
Together, they induce pneumococcal cell lysis and the release of
virulence factors including penumolysin and cell wall component
LTA into the hosts. Therefore, we examined whether CSP1-E1A
could inhibit the synthesis and the release of pneumococcal
murein hydrolases. S. pneumoniae D39 cells were treated with CSP1
(100 ng/ml) alone or simultaneously with increasing amounts of
CSP1-E1A (0, 100, 200, 400 or 800 ng/ml), and subjected to
zymogram analysis. As shown in Figures 6A–6C, The expression
of CbpD and LytA decreased by 63% and 44% respectively when
D39 cells were simultaneously treated with a combination of
100 ng/ml CSP1 and 200 ng/ml CSP1-E1A. The decrease is
even more profound as the concentrations of CSP1-E1A was
increased to 400 ng/ml or 800 g/ml, reducing the expression of
LytA by 73% and 72% (Fig. 6B). Similarly, at the concentrations
of 400 ng/ml or 800 g/ml, CSP1-E1A reduced the expression of
CbpD by 87% and 94%, respectively (Fig. 6C). Inhibition of cpbD
promoter activity (Fig. 6D) mirrored the zymogram analysis.
These results suggest that CSP1-E1A is able to inhibit the
expression of virulence genes regulated by competence regulon.
CSP1-E1A attenuates the virulence of S. pneumoniae
during infection of mouse lungs
The ability of CSP1-E1A to inhibit the expression of LytA and
CbpD in vitro reveals the possibility of using this peptide analogue
to attenuate pneumococcal infection. We examined whether
CSP1-E1A could attenuate the virulence of S. pneumoniae D39
using mouse model of acute pneumonia in two independent
experiments. In Experiment 1, adult CD1 mice (groups of 10) were
intranasally infected with D39 alone or a mixture of D39 and
20 mg CSP1-E1A. Animals were monitored closely, and those that
were moribund were considered dead. As shown in Figure 7A,
inclusion of CSP1-E1A in the infection mix significantly reduced
the mortality rate of infected mice from 60% (D39 alone) to 30%
(D39 coinoculated with CSP1-E1A). However, the difference in
kinetics of mouse survival between the two groups was not
statistically significant (p=0.21) as analyzed by the log rank
(Mantel-Cox) survival analysis. Thus, we repeated the experiment
with higher number of mice and increased concentration of CSP1-
E1A. In Experiment 2, CD1 mice (groups of 20) were intranasally
infected with D39 alone or a mixture of D39 and 100 mg CSP1-
E1A. As shown in Figure 7B, increasing the CSP1-E1A
concentration to 100 mg/mouse in the infection mix significantly
reduced the mortality rate of infected mice from 75% (D39 alone)
to 40% (D39 coinoculated with CSP1-E1A). In addition, the
kinetics of death was delayed, and was statistically significant
Figure 2. The first and third amino acid residues of CSP1 are
essential for induction of competence. (A) D39pcomX::lacZ cells
were incubated with CSP1 or with individual modified peptides at a
final concentration of 100 ng/ml for 30 min. The ability of each peptide
to induce competence regulon was measured by induction of the comX
promoter in D39pcomX::lacZ. The amino acid substitution of 1
st amino
acid (CSP1-E1A) and 3
rd amino acid (CSP1-R3A) in the N-terminus
abolished the peptide’s ability to induce the expression of comX. (B)
D39 cells were exposed to 100 ng/ml of CSP1 or individual modified
peptides. DNA transformation was performed using the rpsL gene.
Transformants were selected on THB agar containing 100 mg/ml
streptomycin. Experiments were performed in triplicates and repeated
three times. The means 6 SD of one typical experiment are shown.
*p,0.01 when compared against CSP1-treated cells.
doi:10.1371/journal.ppat.1002241.g002
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kinetics were indistinguishable between mice infected with D39
alone or in mice infected with a mixture of D39 and 100 mg CSP1-
R3A (Fig. 7C) (p=0.96). These results suggest that CSP1-E1A is
uniquely able to attenuate virulence mechanisms regulated by the
competence regulon during S. pneumoniae-mediated lung infections.
CSP1-E1A inhibits the horizontal gene transfer in vivo
The competence regulon plays a role in the acquisition and
spread of antibiotic resistant genes in S. pneumoniae [7–9]. In vivo
gene uptake and transformation of S. pneumoniae have been
previously reported to occur at extremely low frequency [28–
31]. As we have shown above, CSP1-E1A has the ability to
competitively inhibit CSP1-mediated DNA transformation, and
attenuate the development of spontaneous competence in S.
pneumoniae in vitro. Here, we examined whether CSP-E1A could
inhibit acquisition of the streptomycin resistance rpsL gene in vivo,
using mouse models of acute pneumonia and bacteremia that we
had previously described [20]. Adult CD1 mice were intranasally
or intraperitoneally infected with a transformation mixture
Figure 3. Dose dependent inhibition of comX expression and DNA transformation by CSP-E1A. (A–B) CSP-E1A but not CSP1-R3A inhibits
CSP1-mediated induction of comX in a dose dependent manner. D39pcomX::lacZ cells were exposed to 100 ng/ml of CSP1 alone or simultaneously
with increasing concentrations of CSP-E1A or CSP-R3A. The activity of comX gene promoter was measured by b-galactosidase activity. (A) CSP-E1A
competitively inhibits the ability of CSP1 to induce comX. (B) CSP-R3A is unable to induce comX, and does not competitively inhibit CSP1. (C–D) CSP-
E1A but not CSP1-R3A outcompetes and inhibits CSP1-mediated genetic transformation in a dose dependent manner. In vitro transformation was
performed by treating D39 with 100 ng/ml CSP1 alone or simultaneously with increasing concentrations of CSP1-E1A or CSP1-R3A. Purified PCR
product harboring a mutated rpsL gene was used for genetic transformation. Transformants were selected on THB agar plates supplemented with
100 mg/ml streptomycin. CSP1-E1A competitively inhibited the ability of CSP1 to induce DNA transformation (C). CSP1-R3A was unable to
competitively inhibit DNA transformation (D). Experiments were performed in triplicates and repeated three times. The means 6 SD of one typical
experiment are shown. *p,0.01 when compared against cells treated with CSP1 only.
doi:10.1371/journal.ppat.1002241.g003
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transformation mixture composed of D39 bacteria and rpsL donor
DNA and CSP1 and CSP1-E1A. To ensure that no transforma-
tion occurred outside animals, each component of the transfor-
mation mixture was kept on ice. Individual transformation
components were mixed on ice and immediately inoculated into
the animals. Plating of the ice-cold transformation mixture before
infection or at time intervals 10, 20 and 30 min after infection did
not give rise to any transformants (data not shown). Intranasally-
infected mice were incubated for 6 hr whereas intraperitoneally-
infected mice were incubated until moribund (,16–24 hr). As
shown in Table 2, all five mice intranasally-infected with the D39-
rpsL DNA-CSP1 mixture gave rise to a range of 3 to 41
streptomycin resistant transformants out of the total lung output of
10
6–10
7 D39 cells. In contrast, no streptomycin resistant D39 was
recovered in the five mice infected with D39-rpsL DNA-CSP1-
CSP1-E1A mixture. Similarly as shown in Table 3, all four mice
intraperitoneally-infected with the D39-rpsL DNA-CSP1 mixture
gave rise to a range of 273 to 517 streptomycin resistant
transformants out of the total 10
8 D39 cells. In contrast, no
streptomycin resistant D39 cells were recovered in the four mice
intraperitoneally-infected with D39-rpsL DNA-CSP1-CSP1-E1A.
Collectively, these results suggest that CSP1-E1A is efficient in
suppressing the ability of CSP1 to activate competence regulon in
vivo.
Spontaneous transformation of encapsulated S. pneumoniae
strains including D39 occurs at extremely low frequency in vivo.
Thus, CSP1 was included to increase the efficiency of DNA
transformation experiments reported in Tables 2 and 3. Inclusion
of CSP1 beckoned the question of whether CSP1-E1A could
attenuate natural transformation events in vivo. Natural transfor-
mation experiments were performed using a capsule mutant cap3A
(Table 1) derived from a serotype 3 isolate 0100993 [20]. The
colonies of serotype 3 S. pneumoniae isolates are large and mucoid,
and can be easily distinguished from small colonies formed by non-
encapsulated rough mutants. Mice were intraperitoneally inocu-
lated with a mixture of 3610
9 cap3A cells and 100 mgo f
chromosomal DNA from 0100993, or with a mixture of 3610
9
cap3A cells and 100 mg of 0100993 chromosomal DNA and 100 mg
of CSP1-E1A. Higher amount of CSP1-E1A was used because we
did not know the length of the inhibitory effect of this peptide
analogue in vivo. In addition, the timing of S. pneumoniae cells
entering the competent state for DNA transformation in vivo was
also not clear. Transformation mixtures were assembled under ice-
cold condition as described for Tables 2 and 3. Plating of
transformation mixtures immediately before and after inoculation
did not recover any transformants (data not shown). As shown in
Table 4, transformants with wild-type capsule were recovered
from four of the five mice inoculated with the mixture of cap3A
bacteria and 0100993 genomic DNA. In contrast, transformants
with wild-type capsule were only recovered from one out of five
mice co-inoculated with cap3A bacteria and 0100993 DNA and
CSP1-E1A. Furthermore, we used CSP1-R3A (Fig. 1) as a control
to demonstrate the specificity of CSP1-E1A inhibition. CSP1-R3A
was unable to inhibit development of natural competence in vivo
(Table 4). In the group treated with a mixture of 3610
9 cap3A cells
and 100 mg of 0100993 chromosomal DNA and 100 mg of CSP1-
R3A, transformants were isolated from all the 5 mice, indicating
high concentration of CSP1-R3A was unable to inhibit natural
DNA transformation in vivo. These results suggest that CSP1-E1A
has the unique ability to reduce the incidence of natural DNA
transformation process in vivo.
CSP1-E1A is not bacteriostatic against S. pnuemoniae
A previous study has shown that CSP2 has bacteriostatic activity
against S. pneumoniae [32]. To rule out non-specific effects due to a
much higher concentration of CSP1-E1A used in the virulence
attenuation (Fig. 7B) and in vivo natural transformation (Table 4)
studies, we examined whether CSP1-E1A was bacteriostatic against
S. pneumoniae. As shown in Figure S1A, CSP1 at concentrations of
20 mgo r1 0 0mg caused a slight delay in the growth of D39 cells. In
contrast, same concentrations of CSP1-E1A or CSP1-R3A did not
slow the growth of D39 cells (Fig. S1B–S1C). These results suggest
that high concentrations of CSP1-E1A is not bacteriostatic, and that
attenuation of virulence and DNA transformation by CSP1-E1A is
due to inhibition of competence regulon induction.
A CSP2 analogue CSP2-E1A effectively inhibits the
competence development and transformation in ComD2
strain TIGR4
Because CSP1-E1A is an efficient inhibitor of competence
induced by CSP1, we hypothesize that a synthetic CSP2 analogue
with the substitution of first residue (glutamate) with alainine
(CSP2-E1A) will competitively inhibit CSP2 (Fig. 1). We examined
the ability of CSP2-E1A to inhibit the induction of competence by
CSP2 in the compatible ComD2 strain TIGR4 (Table 1). CSP2-
E1A was barely able to induce the promoter activity of comX
(Fig. 8A), and its ability to induce DNA transformation was
reduced by approximately 3 logs when compared to CSP2
(Fig. 8B). Importantly, CSP2-E1A competitively inhibited the
ability of CSP2 to induce comX expression in the TIGR4pcomX::
lacZ cells in a concentration-dependent manner (Fig. 8C).
Similarly, CSP2-E1A inhibited the ability of CSP2 to induce
DNA transformation of TIGR4 in a concentration dependent
manner. At equal concentration of 100 ng/ml, CSP2-E1A
reduced the number of transformants generated by CSP2 by
68% (Fig. 8D). At higher concentrations of 400 and 800 ng/ml,
CSP2-E1A almost completely abolished CSP2-mediated DNA
transformation. These results suggest that CSP2-E1A is a strong
competitive inhibitor of comX expression and DNA transformation
in ComD2 strain TIGR4.
Figure 4. Time-dependent inhibition of CSP1 by CSP1-E1A.
CSP1-E1A competitively inhibits CSP1 in a time-dependent manner.
D39pcomX::lacZ cells (OD 600nm 0.1) were pre-exposed to 100 ng/ml
CSP1. At Time 0, 5, 10, 15, 20, 25 and 30 min, CSP-E1A (100 ng or
800 ng) was added to chase CSP1. Cells were collected 30 min after
each addition of CSP1-E1A for b-galactosidase assays. Activation of
comX promoter was calculated against D39pcomX::lacZ cells exposed to
CSP1 alone (100%). Experiments were performed in triplicates and
repeated three times. The means 6 SD of one typical experiment are
shown.
doi:10.1371/journal.ppat.1002241.g004
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S. penumoniae strains with incompatible ComD subtypes
A previous study has shown that individual CSP peptide is
capable of inducing the competence of DNA transformation in S.
pneumoniae strains expressing an incompatible ComD subtype,
albeit at lower efficiency [19]. For example, CSP1 is able to induce
the competence at lower efficiency in TIGR4, a pneumococcal
strain with an incompatible ComD2 subtype. Because the first
amino acid (glutamate) at the N-terminus is conserved across all six
CSP subtypes, this raises the possibility that our CSP analogues
CSP1-E1A and CSP2-E1A can be broad spectrum in their ability
to inhibit the development of competence, horizontal gene
transfers and virulence, regardless of S. pneumoniae serotypes or
ComD subtypes. To test this hypothesis, we examined the ability
of CSP1-E1A and CSP2-E1A (Table 1) to cross inhibit the
induction of comX and DNA transformation in ComD2 strain
TIGR4 or ComD1 strain D39, respectively. As shown in
Figure 9A, CSP1-E1A inhibited the induction of comX and DNA
transformation by CSP2 in TIGR4 by a concentration dependent
manner, though at a lesser efficiency. For example, CSP1-E1A at
800 ng/ml was able to inhibit approximately 50% of comX
promoter activity in the presence of 100 ng/ml CSP2. Similarly,
CSP1-E1A (800 ng/ml) decreased the CSP2-induced DNA
transformation frequency by 67% (Fig. 9B).
Finally, we examined the ability of CSP2-E1A to inhibit the
induction of comX and DNA transformation by CSP1 in the
ComD1 strain D39. As shown in Figure 9C, CSP2-E1A inhibited
CSP1-mediated comX induction and DNA transformation in D39
by a concentration dependent manner. For example, CSP2-E1A
at 800 ng/ml was able to inhibit approximately 77% of comX
induction and 90% of DNA transformation in the presence of
100 ng/ml CSP1 (Fig. 9D). Collectively, these results suggest that
CSP1-E1A and CSP2-E1A have the potential of inhibiting the
development of competence, horizontal gene transfer and
virulence, regardless of pneumococcal serotypes and CSP/ComD
subtypes.
Figure 5. CSP1-E1A delays and inhibits the spontaneous development of competence in S. pneumoniae in a concentration-
dependent manner. (A–B) D39pcomX::lacZ and D39pcbpD::lacZ cells grown in THB (pH 8.3) were incubated with 100 ng/ml, 1 mg/ml or 10 mg/ml
of CSP1-E1A or with same volume of sterile water, and monitored for comX promoter activity (A) or for the cbpD promoter activity (B) by b-
galactosidase assays at indicated time intervals. (C) CSP1-E1A does not inhibit the growth of S. pneumoniae. Similar results were obtained from three
independent experiments. The data from one typical experiment are shown.
doi:10.1371/journal.ppat.1002241.g005
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The competence regulon is known to regulate DNA transfor-
mation and virulence in S. pneumoniae [7–9,20–24]. In this study,
we explored the use of synthetic analogues of CSPs to
competitively inhibit: (i) the development of competence, (ii)
horizontal gene transfer, and (iii) virulence, under both in vitro and
in vivo experimental conditions. Amino acid substitution or deletion
of conserved residues in C-terminus of CSP1 did not alter their
ability to induce competence and DNA transformation. In
contrast, amino acid substitutions on the first (CSP1-E1A) and
third residue (CSP1-R3A) on the N-terminus impair the ability of
these CSP analogues to induce competence. Our findings are
consistent with the previously thesis work by Coomaraswamy [33],
which has been summarized by Haverstein and Morrison [34]. By
alanine scanning, Coomaraswamy demonstrates that both the N-
terminus and the central region are more important than the C-
terminus of CSP1 for the induction of competence regulon. One
discrepancy of our finding from that of Coomaraswamy is on the
requirement of 2
nd amino acid residue on the N-terminus.
Coomaraswamy has shown that substituting the methionine with
an alanine reduces the ability of the CSP1-M2A to induce
competence by 96%. In contrast, our analysis suggests that the
methionine residue is dispensable for competence induction. One
possible explanation for the discrepancy is that our comX induction
and DNA transformation experiments were performed with
100 ng/ml CSP1-M2A, approximately 10-fold higher than the
amounts used by Coomaraswamy. Thus, despite its lower activity,
excess amounts of CSP1-M2A might have masked our ability to
see reduced efficiency of this analogue to induce competence.
Figure 6. CSP1-E1A inhibits the expression of competence regulated virulence factors LytA and CbpD in vitro. (A) CSP1-E1A attenuates
the expression of LytA and CbpD. D39 cells (OD 600nm 0.1) were exposed to CSP1 (100 ng/ml) alone or simultaneously to increasing amounts of
CSP1-E1A (0, 100, 200, 400 or 800 ng/ml). Cells were incubated for 30 minutes, lysed and subjected to zymogram analysis. Lytic activity was observed
as bands of clear zones in the turbid gel. Experiments were repeated three times. The gel from one typical experiment is shown. (B–C) Densitometry
analysis of LytA (B) and CbpD (C) from the zymogram in A. (D) CSP1-E1A inhibits the promoter activity of cbpD in a concentration dependent manner.
D39pcbpD::lacZ cells were exposed to CSP1 alone, pure water alone or to a mixture of 100 ng/ml CSP1 and CSP-E1A.Cells were collected for b-
galacosidase assays 30 min after exposure.
doi:10.1371/journal.ppat.1002241.g006
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capable of competitively inhibiting the induction of competence
and DNA transformation by CSP1. CSP1-E1A is able to
effectively compete with CSP1 even after 25 min pre-exposure
of S. pneumoniae to the latter. Furthermore, CSP1-E1A is able to
inhibit the development of spontaneous competence in S.
pneumoniae in a concentration dependent manner. Importantly,
CSP1-E1A is able to attenuate the expression of competence-
regulated pneumococcal virulence factors LytA and CbpD in vitro,
and reduced the mortality of mice in a pneumonia model of lung
infection by S. pneumoniae. In addition, we provide evidence that
CSP1-E1A is able to inhibit the horizontal gene transfer of the
Figure 7. CSP1-E1A attenuates the mortality of mice infected
with S. pneumoniae. (A) Six-week old CD-1 mice (n=10) were
intranasally infected with S. pneumoniae D39 (3610
6,5 0ml) alone, or
with a mixture of D39-CSP-E1A (20 mg/mouse). Infected mice were
monitored every 6 hr. Moribund mice were euthanized and considered
dead. The difference in kinetics of mouse survival between the two
groups was not statistically significant (p=0.21) as analyzed by the log
rank (Mantel-Cox) survival analysis. (B) Infection assay was repeated
with CD-1 mice (n=20) using D39 (2610
6,5 0ml) alone or with a mixture
of D39-CSP-E1A (100 mg/mouse). Infected mice were monitored as
described in (A). The kinetics of death was significantly delayed
(p=0.01) as determined by the log rank (Mantel-Cox) survival analysis.
(C) The survival kinetics was indistinguishable between mice infected
with D39 alone or in mice infected with a mixture of D39 and 100 mg
CSP1-R3A (p=0.96).
doi:10.1371/journal.ppat.1002241.g007
Table 2. CSPP1-E1A inhibits the ability of S. pneumoniae to
acquire the rpsL streptomycin resistance gene in mouse lungs
during acute pneumonia.
Treatment Mice
# of output
bacteria/lung # transformants
CSP1 1 5.7610
6 3
2 3.3610
7 15
3 7.2610
6 7
4 1.4610
7 23
5 2.3610
7 41
CSP1 + CSP1-E1A 1 5.3610
6 0
2 1.7610
7 0
3 2.1610
7 0
4 3.2610
7 0
5 1.2610
7 0
Mice (n=5) were intranasally inoculated with D39 (3610
7,5 0ml volume)
supplemented with 100 ng CSP1 and 10 mgo frpsL gene DNA, or D39
supplemented with a mixture 100 ng CSP1, 800 ng CSP1-E1A and 10 mgo frpsL
gene DNA in THB. Mouse lungs were harvested 6 hr post-inoculation,
homogenized and plated on THB agar for total bacterial load or THB agar
supplemented with streptomycin (100 mg/ml) for rpsL transformants.
doi:10.1371/journal.ppat.1002241.t002
Table 3. CSPP1-E1A inhibits the ability of S. pneumoniae to
acquire the rpsL streptomycin resistance gene in mouse
peritoneal cavity.
Treatment Mice
# of output
bacteria/spleen
#
transformants
CSP1 1 3.1610
8 273
2 4.5610
8 251
3 2.7610
8 372
4 5.7610
8 517
CSP1 + CSP1-E1A 1 1.3610
8 0
2 4.3610
8 0
3 2.2610
8 0
4 2.4610
8 0
Mice were intraperitoneally infected with D39 (3610
7,5 0ml volume)
supplemented with 100 ng CSP1 and 10 mgo frpsL gene DNA, or D39
supplemented with a mixture 100 ng CSP1, 800 ng CSP1-E1A and 10 mgo frpsL
gene DNA in THB. Mouse spleens were harvested between 16–24 hr post-
infection, homogenized and plated on THB agar for total bacterial load or THB
agar supplemented with streptomycin (100 mg/ml) for rpsL transformants.
doi:10.1371/journal.ppat.1002241.t003
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Finally, we demonstrate a broader applicability of the peptide
inhibitor strategy. CSP1-E1A and CSP2-E1A are able to cross
inhibit the induction of competence and DNA transformation in
pneumococcal strains with incompatible ComD subtypes. For
example, CSP1-E1A is able to reduce the CSP2-mediated
competence and DNA transformation in ComD2 strain TIGR4.
Similarly, CSP2-E1A is able to cross inhibit the CSP1-mediated
competence and DNA transformation in ComD1 strain D39.
Among the five CSP1 analogues, we found that only CSP1-E1A
inhibits CSP1-mediated competence in time and concentration-
dependent manners. These results suggest that glutamate, the first
amino acid residue of CSPs, is only required for the activity of
CSPs. Substituting the glutamate with alanine disrupts the ability
of the analogue to activate ComD1, but does not interfere with its
binding affinity to ComD1. Competitive inhibition of CSP1 by
CSP1-E1A suggests that this analogue, which barely activates
competence, can bind to the receptor kinase ComD1, and
outcompete CSP1. In contrast, another CSP1 analogue, CSP1-
R3A, not only loses the ability to induce competence, but also
could not out compete CSP1 even when added in over-saturating
concentrations. This observation indicates that CSP1-R3A has lost
its ability to bind and activate ComD1. The importance of the first
glutamate residue has been confirmed by our data demonstrating
that the synthetic analogue CSP2-E1A also efficiently inhibits the
CSP2-mediated DNA transformation in the compatible ComD2
strain TIGR4.
Several studies have revealed that the competence regulon of
S. pneumoniae is important for virulence in mammalian hosts [20–
24]. For example, we have previously shown that the loss-of-
function mutation in the comB gene, which encodes an accessory
protein of the ComA ABC transporter for the export of CSP, is
attenuated in a mouse model of bacteremia infection [20].
Mutation of CSP receptor gene comD severely attenuates
virulence in both mouse models of pneumonia and bacteremia
infection [20]. Also, microarray analysis has showed that some
virulence and stress responsive genes are upregulated during
development of competence, suggesting that genes that are
important for the fitness of S. pneumoniae are also regulated by
competence CSP-ComDE cascade [14]. Thus, suppression of the
CSP-ComDE cascade or downstream genes dependent on this
signaling pathway may attenuate the virulence of this pathogen.
Our results, which show that CSP1-E1A delays the kinetics and
the rate of mouse mortality, demonstrate that this peptide has the
potential to inhibit the virulence of S. pneumoniae by disrupting the
CSP-ComDE- dependent competence regulon. Our findings are
in agreement with previous reports by Oggioni et al,w h i c hs h o w
that administration of CSP in a mouse model of pneumonia
infection increases virulence of pneumococci [35], suggesting
that competence regulon is important for lung infection. In
contrast, the same authors also reported that intravenous (IV)
injection of CSP reduces virulence in an IV model of mouse
bacteremia [32]. Based on this finding, one can surmise that
administration of CSP1-E1A may have the unintended conse-
quence of exacerbating virulence in IV model of mouse
bacteremia. However, one unresolved issue with the results of
the IV model of sepsis [32] is that it is in disagreement with the
findings by Lau et al [20], which showed the requirement of
competence regulon during pneumococcal-mediated sepsis. The
discrepansy can be explained because the sepsis studies by Lau et
al was performed by intraperitoneal model of infection whereas
the studies by Oggionu et al was performed by IV model of
infection. Neverthelss, collectively, these studies indicate the
important contribution of the pneumococcal competence regulon
to virulence during mouse model of pneumonia infection, and
offer an tentalizing clue that the competence system as interesting
drug target to combat pulmonary pneumonia. In contrast,
inhibition of competence regulon by systemic delivery of CSP1-
E1A in an IV model of bacteremia should be avoided until
further clarification.
Table 4. CSPP1-E1A attenuates the ability of cap3A mutant S. pneumoniae to acquire capsule gene during natural transformation
in mouse peritoneal cavity.
Treatment Mice # of transformants/spleen
cap3A bacteria + 0100993 chromosomal DNA 14 . 7 610
6
22 . 5 610
6
32 . 0 610
7
47 . 7 610
6
50
cap3A bacteria + 0100993 chromosomal DNA + CSP1-E1A 10
20
30
43 . 3 610
6
50
cap3A bacteria + 0100993 chromosomal DNA + CSP1-R3A 17 . 3 610
5
24 . 2 610
6
32 . 7 610
5
41 . 1 610
7
55 . 4 610
6
Mice were intraperitoneally infected with S. pneumoniae cap3A mutant bacteria (3610
9,1 0 0ml volume) supplemented with 100 mg of chromosomal DNA from the
parental wild-type strain 0100993 in the presence or absence of 100 mg CSP1-E1A or CSP1-R3A. Mouse spleens were harvested at 24 hr post-infection, homogenized,
serially diluted and plated on THB agar for enumeration of mucoid colonies.
doi:10.1371/journal.ppat.1002241.t004
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lactams, macrolides, and other antibiotic classes has escalated
dramatically throughout the world [4–6,36–39]. While conjuga-
tive elements appear to be the most important causes for the
spread of antibiotic resistance genes in S. pneumoniae [40–43],
horizontal gene transfer of penicillin binding protein genes has
occurred in clinical isolates of S. pneumoniae [44]. Importantly, it
has been shown that under in vitro conditions, antibiotic stress
induces genetic transformability in S. pneumoniae [45]. This suggests
that under certain in vivo circumstances, instead of being killed, S.
pneumoniae actively exploits the opportunity of antibiotic stress to
acquire exogenous genes. These authors also reported that unlike
wild type S. pneumoniae, antibiotic stress-mediated competence
could not be induced in a comA mutant that lacks the ABC
transporter needed to export CSP, suggesting that this process is
CSP-dependent. Because antibiotic resistance is a serious clinical
concern, the development and use of non-antibiotic based therapy
to reduce horizontal gene transfer is urgently needed. Our studies
suggest that CSP1-E1A and CSP2-E1A competitively inhibit CSP
from binding to ComD, leading to suppression of horizontal gene
transfer. The use of CSP1-E1A and CSP2-E1A, which does not
inhibit the bacterial growth, is predicted to pose less selection
pressure toward the survival of S. pneumoniae. This may alleviate the
emergence of resistance in pneumococcus. More importantly,
CSP1-E1A and CSP2-E1A have the ability to cross inhibit the
induction of the competence regulon in S. pneumoniae strains with
incompatible ComD subtypes. Thus, it may be beneficial to
generate analogues of CSPs as drugs to reduce horizontal transfer
Figure 8. CSP2-E1A inhibits competence development and transformation in ComD2 strain TIGR4. (A–B) CSP2-E1A was drastically
reduced in its ability to induce the promoter activity of comX (A) and DNA transformation in TIGR4 (B). Experiments were performed in triplicates and
repeated three times. The means 6 SD of one typical experiment are shown. *p,0.01 when compared against TIGR4pcomX::lacZ cells (A) or TIGR4
cells (B) treated with CSP2 only. (C) CSP-E2A out-competes CSP2 and inhibits activation of the comX promoter activity. TIGR4pcomX::lacZ cells (OD
600nm 0.1) were incubated with 100 ng/ml CSP2 alone or simultaneously with increasing amounts of CSP2-E1A. The activity of comX promoter was
measured by b-galactosidase assays. (D) CSP-E2A inhibits CSP2-mediated DNA transformation of TIGR4. In vitro transformation was performed by
treating TIGR4 cells with 100 ng/ml CSP2 alone or simultaneously with increasing amount of CSP2-E1A. Purified PCR product of a mutated rpsL gene
was used for genetic transformation. Transformants were selected on THB agar supplemented with 100 mg/ml streptomycin. Experiments in were
performed in triplicates and repeated three times. The means 6 SD of one typical experiment are shown. *p,0.01 when compared against
TIGR4pcomX::lacZ cells (A) or TIGR4 cells (B) treated with CSP2 only.
doi:10.1371/journal.ppat.1002241.g008
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virulence during infection by S. pneumoniae irrespective of their
serotypes. In the same context, chemical inhibitors of that interfere
with CSP functions may be useful as well.
In previously published studies, some of the in vivo transforma-
tion experiments involved infections were allowed to run their
course, and success or failure of gene transfers were expressed by
the number of deceased animals harboring encapsulated or
antibiotic resistant transformants [28–31]. However, at these late
stages of infection, most transformants are expected to have over-
proliferated, and it may be difficult to assess the actual
transformation frequency. Other transformation studies lasted
for eight hr [46,47]. In this study, we used both approaches. We
assessed the infected lungs for streptomycin resistant transformants
6 hr post-infection in an effort to estimate the actual transforma-
tion frequency. Our results suggest that, despite the provision of
CSP1 and abundant amounts of DNA, in vivo transformation
events for the encapsulated wild-type S. pneumoniae strain D39 in
mouse lungs remain low, in the range of 10
26 to 10
27 under our
experimentation conditions. In comparison, we also examined the
in vivo transformation within intraperitoneally-infected mice in
which the infection was allowed to take its full course (, 24 hr),
similar to previously published studies [28–31]. The percentage of
transformants in D39 increases to the range of 10
24 to 10
25. The
different rate of transformation may suggest that the environment
in the lung is more complex and less conducive to DNA uptake
Figure 9. Cross inhibition of competence by CSP1-E1A and CSP2-E1A in S. pneumoniae strains with incompatible ComD subtypes.
(A-B) TIGR4 (ComD2 subtype) or TIGR4pcomX-lacZ cells (OD 600nm 0.1) were incubated with CSP2 alone or simultaneously with increasing amounts
of CSP1-E1A (100–800 ng/ml). (C-D) D39 (ComD1 subtype) or D39pcomX-lacZ cells were incubated with the mixture of 100 ng/ml CSP1 alone or
simultaneously with increasing amounts of CSP2-E1A (100–800 ng/ml). Pneumococcal cells were assayed for ß-galactosidase activity and
transformation frequency 60 minutes after exposure. (A–B) Cross inhibition of competence in ComD2 strain TIGR4 by CSP1-E1A as measured by the
induction of comX promoter activity (A) and transformation frequency (B). (C–D) Cross inhibition of competence in ComD1 strain D39 by CSP2-E1A as
measured by the induction of comX promoter activity (C) and transformation frequency (D). Experiments were performed in triplicates and repeated
three times. The means 6 SD of one typical experiment are shown. *p,0.05 when compared against TIGR4 cells or TIGR4pcomX-lacZ cells treated
with CSP2 alone, or D39 cells or D39pcomX-lacZ cells treated with CSP1 alone.
doi:10.1371/journal.ppat.1002241.g009
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longer period of infection may have allowed more recipient D39
cells to be transformed.
Importantly, we show that CSP1-E1A is also able to attenuate
natural transformation in the absence of exogenously provided
CSP1. The capsule-deficient cap3A mutant derived from the
serotype 3 strain 0100993 was used as recipient. It is well known
that natural transformation frequency of capsule-deficient S.
pneumoniae mutants is much higher than their respective encapsu-
lated parental wild-type strains. Furthermore, recipients that have
acquired the wild-type capsule gene will be more resistant to
phagocytosis by host leukocytes, allowing a better possibility for
the transformants to proliferate inside the host. Because of the
higher transformation frequency was anticipated for the rough
cap3A mutants, larger amounts of CSP1-E1A was used to attenuate
natural transformation to ensure that the inhibition effect of CSP1-
E1A could outlast and suppress spontaneous development of
competence of cap3A cells in the peritoneal cavity. In contrast, the
presence of capsule in D39 cells reduces the spontaneous
transformation frequency to a very low level. Not surprisingly,
800 ng of CSP1-E1A was adequate to completely abolish
transformation of D39 cells in vivo.
In summary, we have demonstrated the efficacy of using
competitive inhibitor of CSPs to attenuate virulence and to
inhibit horizontal gene transfer in S. pneumoniae. Because
competence peptide-mediated quorum sensing systems are
conserved in many pathogenic species of Gram-positive bacteria
[48–52], the strategy of using peptide analogue may be applicable
to reduce the incidence of horizontal gene transfer and
acquisition of antibiotic resistance genes, and to also treat lung
infections mediated by this class of pathogens. In addition,
competence systems in other streptococcal species, including S.
mitis, are very similar to that of S. pneumoniae, lending to the idea
that the former could be transformed by pneumococcal DNA
[53,54]. S. mitis is generally considered as an avirulent species, but
it has the potential to acquire virulence determinants from S.
pneumoniae to transform itself into a pathogen. In this scenario,
CSP1-E1A or CSP2-E1A may be applicable to reduce the
emergence of the new pathogen.
Materials and Methods
Chemicals
All chemicals, except where noted, were purchased from Sigma
Chemical Co. (St. Lois, MO).
Bacterial strains and growth conditions
S. pneumoniae strains D39 [55], R6 [56] and TIGR4 [57] were
generous gifts from Dr. David Briles (University of Alabama-
Birmingham). Strains D39pcomX::lacZ and TIGR4pcomX::lacZ,
both of which carry an insertion of the lacZ gene under the control
of the comX promoter, were generated by transforming D39 and
TIGR4 with the genomic DNA from CPM3 [26]. Strain
D39pcbpD::lacZ was generated using previously described
primers [58]. Briefly, a 500 bp fragment within cbpD gene was
amplified and cloned into lacZ reporter plasmid pEVP3 [59]. The
recombinant plasmid was transformed into D39 to generate
D39pcbpD::lacZ. The capsule-deficient cap3A mutant was gener-
ated by deleting cap3A gene from the serotype 3 clinical isolate
0100993 [20] using the Janus cassette [25]. Aliquots of bacteria
were stored at 270uC in THB containing 25% glycerol. For
routine experiments, bacteria from frozen stocks were streaked
onto THB agar containing 5% defibrinated horse blood and
incubated for 12–24 h at 37uC with 5% CO2. Fresh colonies were
scraped and transferred to THB and grew to desired density as
measured by a spectrophotometer at OD 600nm.
Synthetic CSPs
CSP1, CSP2 and their analogues ($95% purity) were
synthesized by Elim Biopharm (Hayward, CA).
Activation assays of comX and cbpD promoters
The ability of synthetic CSPs to activate the promoters of comX
gene was compared in D39pcomX::lacZ or TIGR4pcomX::lacZ
bacteria grown in THB (pH 6.8) until OD 600nm of 0.1, washed
and resuspended in THB (pH 8.3). Induction of cbpD promoter
was monitored using the D39pcbpD::lacZ cells grown under the
same conditions. CSP1 or CSP2 and their analogues were added
at indicated concentrations to the culture and incubated at 37uC
for 30 min. ß-galactosidase activity was measured according to
previously published protocols [19], and expressed as Miller
units.
In vitro S. pneumoniae transformation assay
In vitro transformation experiments were performed as we had
previously described [20]. Briefly, S. pneumoniae cells were grown to
early log phase (OD 600nm 0.1) in THB (pH 6.8), washed and
resuspended in THB (pH 8.3) containing rpsL DNA (1 mg). CSP1,
CSP2 and their analogues were added alone or in combination at
desirable concentrations. The rpsL gene, which confers resistance
to streptomycin, and its flanking regions (combined length
1633 bp), were amplified from pneumococcal strain CP1296
[27] using the following primers: rpsL upper 59-GGGCTAGTA-
GAAGTAGTTGG-39; rpsL lower: 59-CGGAAGTGTGC-
GAATGCACG-39). The transformation mix was then incubated
at 37uC with 5% CO2 for 1 hr. Transformants were selected on
THB agar supplemented with 100 mg/mL streptomycin.
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Institutional Animal Care and Use
Committee (IACUC) at the University of Illinois at Urbana-
Champaign (Protocol Number: 10144).
Mouse acute pneumonia infection assays
Mice used in this study were housed in positively ventilated
microisolator cages with automatic recirculating water, located in
a room with laminar, high efficiency particle accumulation–
filtered air. The animals received autoclaved food, water, and
bedding. Six-week old adult male CD-1 mice (Charles River,
Boston) (groups of 10) were anesthetized with isoflurane and
intranasally administered 3610
6 CFU of D39 bacteria or D39-
20 mg CSP1-E1A mixture in 50 ml PBS. In a second experiment,
CD-1 mice (groups of 20) were exposed to 2610
6 CFU of D39
bacteria or D39-100 mg CSP1-E1A mixture in 50 ml PBS. The
Infected mice were monitored every 6 hr for 96 hr. Moribund
animals that displayed rough hair coat, hunched posture,
distended abdomen, lethargy or inability to eat or drink were
euthanized.
In vivo horizontal gene transfer studies
The rpsL donor DNA was amplified from pneumococcal strain
CP1296 [25]. S. pneumoniae strain D39 cells were used as recipients.
D39 cells were grown to OD 600nm 0.1 in THB (pH 6.8), washed
and resuspended in fresh THB (pH 8.3). Adult CD-1 mice were
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7,5 0ml
volume) supplemented with a mixture of 100 ng CSP1 and 10 mg
of rpsL gene DNA, or D39 supplemented with a mixture 100 ng
CSP1, 800 ng CSP1-E1A, and 10 mgo frpsL gene DNA in THB.
For natural transformation studies, a capsule-deficient cap3A
mutant (Table 1) derived from a clinical serotype 3 strain
0100993 (20) was used as recipient. Natural transformation were
performed intraperitoneally in mice with 2610
9 cap3A cells and
100 mg of chromosomal DNA from 0100993, with or without
100 mg of CSP1-E1A. No CSP1 peptide was used. For all
transformation assays, individual reagents were kept separately on
ice, mixed and immediately inoculated into animals to prevent the
induction of competence prior to injection. Transformation event
did not occur before or after the experiments because no
transformants was recovered from plating the transformation
mix before or after the experiments (data not shown). For
intranasally infected mice, lungs were harvested 6hr post-infection,
homogenized and plated on THB agar (total output) or THB agar
supplemented with 100 mg/ml streptomycin for transformants.
Intraperitoneally infected mice were monitored until they were
moribund (,16–24 hr) at which time the animals were eutha-
nized, and the spleens were harvested for bacterial enumeration.
The number of total bacteria and streptomycin resistant
transformants in spleens were enumerated as described above.
S. pnuemoniae growth inhibition by CSP1 and
derivatives. D39 cells were collected at early log phase (OD
600nm 0.1). Cells (2610
6 cfu) were resuspended in 50 ml of sterile
PBS and incubated with 20 mg or 100 mg of CSP1, CSP1-E1A or
CSP1-R3A or CSP1, and incubated on ice for 10 min. THB
(500 ml) was added to the cells/peptide mixtures, and incubated at
37uCi naC O 2 incubator. Bacterial growth was monitored at OD
600nm using a spectrophotometer for the indicated time intervals.
Zymogram analysis of murein hydrolases
D39 cells were grown in THB (pH 6.8) to OD 600nm of 0.1.
Cells were washed and resuspended in fresh THB (pH 8.3). Cells
were exposed to CSP1 (100 ng/ml) alone or to a combination of
CSP1 and increasing amounts of CSP1-E1A (0, 100, 200, 400 or
800 ng/ml). After 30 minutes of incubation, cells were lysed by
mixing with 2X SDS loading buffer, and subjected to zymogram
analysis as previously published [60]. Lytic activity was observed as
bands of clear zones in the turbid gel.
Statistical analyses
Statistical analyses of in vitro experiments were performed using
the Student’s t-test and one-way analyses of variance (ANOVA).
Statistical significance of survival studies was performed using the
log-rank (Mantel-Cox) test in GraphPad Prism statistical software
package. A significant difference was considered to be p,0.05.
Accession numbers
gene=‘‘comC1’’, locus_tag=‘‘SPD_2065’’, db_xref=‘‘Gen-
eID:4441955’’;
gene=‘‘comD’’, locus_tag=‘‘SPD_2064’’, db_xref=‘‘Gen-
eID:4442986’’;
gene=‘‘comE’’, locus_tag=‘‘SPD_2063’’, db_xref=‘‘Gen-
eID:4441307’’;
gene=‘‘comX1’’, locus_tag=‘‘SPD_0014’’, db_xref=‘‘Gen-
eID:4441078’’;
gene=‘‘comX2’’, locus_tag=‘‘SPD_1818’’, db_xref=‘‘Gen-
eID:4442416’’;
gene=‘‘cbpD’’, locus_tag=‘‘SPD_2028’’, db_xref=‘‘Gen-
eID:4442443’’;
gene=‘‘cap3A’’, GenBank: Z47210.1.
Supporting Information
Figure S1 CSP1-E1A is not bacteriostatic against S.
pneumoniae. (A-C) D39 cells (2610
6 cfu) (OD 600nm 0.1) were
resuspended in 50 ml of PBS and incubated with 20 mg or 100 mg
of CSP1, CSP1-E1A or CSP1-R3A or CSP1. After 10 min of
incubation on ice, the cells/peptide mixture was added to 500 ml
of THB, and incubated at 37uC. Bacterial growth was monitored
by OD 600nm for the indicated time intervals. Experiments were
performed in triplicates and repeated three times. The means 6
SD of one typical experiment are shown.
(TIF)
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